De uønskede hændelser, som er indberettet om mycophenolatmofetil efter markedsføringen svarer til dem, som er set i de kontrollerede nyre -, hjerte - og levertransplantationsstudier.
The following undesirable effects cover adverse reactions from post-marketing experience: the types of adverse reactions reported during post-marketing with mycophenolate are similar to those seen in the controlled renal, cardiac and hepatic transplant studies.